Fluorescein-polyethyleneimine coated gadolinium oxide nanoparticles as T1 magnetic resonance imaging (MRI)-cell labeling (CL) dual agents

RSC Advances

Volumn 2, Issue 29, 2012, Pages 10907-10915

  Xu, Wenlong ^a   Park, Ja Young ^a   Kattel, Krishna ^a   Ahmad, Md Wasi ^a   Bony, Badrul Alam ^a   Heo, Woo Choul ^a   Jin, Seonguk ^b   Park, Jang Woo ^b   Chang, Yongmin ^b   Kim, Tae Jeong ^a   Park, Ji Ae ^c   Do, Ji Yeon ^a   Chae, Kwon Seok ^a   Lee, Gang Ho ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AFTER-TREATMENT; AQUEOUS SAMPLES; CELL LABELING; CONFOCAL IMAGE; CONTRAST ENHANCEMENT; COUPLING METHODS; GADOLINIUM OXIDE; GRAFTING DENSITIES; HYDRODYNAMIC DIAMETER; LIVER TUMORS; MR IMAGES; PARTICLE DIAMETERS; SAMPLE SOLUTION; SURFACE COATINGS; TAIL VEINS;

ABSORPTION SPECTROSCOPY; COATINGS; FLUORESCENCE; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; RATS; SYNTHESIS (CHEMICAL);

GADOLINIUM;

EID: 84871055776     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c2ra21052e     Document Type: Article

References (49)

1. M. Lewin N. Carlesso C. -H. Tung X. -W. Tang D. Cory D. T. Scadden R. Weissleder Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Nat. Biotechnol. 2000 18 410 414
2. F. Lux A. Mignot P. Mowat C. Louis S. Dufort C. Bernhard F. Denat F. Boschetti C. Brunet R. Antoine P. Dugourd S. Laurent L. V. Elst R. Muller L. Sancey V. Josserand J.-L. Coll V. Stupar E. Barbier C. Rémy. A. Broisat C. Ghezzi G. L. Duc S. Roux P. Perriat O. Tillement Ultrasmall rigid particles as multimodal probes for medical applications Angew. Chem., Int. Ed. 2011 50 12299 12303
3. R. H. Hashemi, W. G. Bradley and C. J. Lisanti, MRI The Basics, Lippincott Williams & Wilkins, New York, 2004
4. R. B. Lauffer Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design Chem. Rev. 1987 87 901 927
5. P. Caravan J. J. Ellison T. J. McMurry R. B. Lauffer Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications Chem. Rev. 1999 99 2293 2352
6. C. F. G. C. Geraldes S. Laurent Classification and basic properties of contrast agents for magnetic resonance imaging Contrast Media Mol. Imaging 2009 4 1 23
7. G. J. Strijkers W. J. M. Mulder G. A. F. van Tilborg K. Nicolay MRI contrast agents: current status and future perspectives Anti-Cancer Agents Med. Chem. 2007 7 291 305
8. J. D. Rocca W. Lin Nanoscale metal-organic frameworks: magnetic resonance imaging contrast agents and beyond Eur. J. Inorg. Chem. 2010 3725 3734
9. C. P. Constantin A. Doaga A. M. Cojocariu I. Dumitru O. F. Caltun Improved contrast agents for magnetic nuclear resonance medical imaging J. Adv. Res. Phys. 2011 2 1 011106
10. I. Coroiu Al. Darabont and D. E. Demco, Potential contrast agents for magnetic resonance imaging Appl. Magn. Reson. 1998 15 531 538
11. J. Y. Park E. S. Choi M. J. Baek G. H. Lee S. Woo Y. Chang Water-soluble ultra small paramagnetic or superparamagnetic metal oxide nanoparticles for molecular MR imaging Eur. J. Inorg. Chem. 2009 2477 2481
12. 3@MnO) nanoparticles for MRI contrast agent Eur. J. Inorg. Chem. 2010 4555 4560
13. 1 MR images ACS Nano 2009 3 3663 3669
14. M. Engström A. Klasson H. Pedersen C. Vahlberg P. -O. Käll K. Uvdal High proton relaxivity for gadolinium oxide nanoparticles Mag. Reson. Mater. Phys. Biol. Med. 2006 19 180 186
15. 3 nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning Nanotechnology 2007 18 395501
16. 3 nanocrystals: a bifunctional material with combined fluorescent labeling and MRI contrast agent properties J. Phys. Chem. C 2009 113 6913 6920
17. 3 nanoparticles for MRI contrast enhancement Langmuir 2010 26 5753 5762
18. A.-A. Guay-Bégin P. Chevallier L. Faucher S. Turgeon M.-A. Fortin Surface modification of gadolinium oxide thin films and nanoparticles using poly(ethylene glycol)-phosphate Langmuir 2012 28 1 774 782
19. 1 MRI contrast enhancement Chem. Mater. 2011 23 3714 3722
20. J. -L. Bridot A.-C. Faure S. Laurent C. Rivière C. Billotey B. Hiba M. Janier V. Josserand J.-L. Coll L. V. Elst R. Muller S. Roux P. Perriat O. Tillement Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging J. Am. Chem. Soc. 2007 129 5076 5084
21. 3 nanoparticles inside single-wall carbon nanohorns J. Phys. Chem. B 2006 110 5179 5181
22. H. Hifumi S. Yamaoka A. Tanimoto D. Citterio K. Suzuki Gadolinium-based hybrid nanoparticles as a positive MR contrast agent J. Am. Chem. Soc. 2006 128 15090 15091
23. 3: synthesis and applications of magnetic resonance contrast agents and template particles for hollow spheres and hybrid composites Adv. Funct. Mater. 2008 18 766 776
24. I.-F. Li C.-S. Yeh Synthesis of Gd doped CdSe nanoparticles for potential optical and MR imaging applications J. Mater. Chem. 2010 20 2079 2081
25. 3 nanoparticles-physical characterization and NMR relaxation properties Chem. Mater. 2006 18 2499 2505
26. W. J. Rieter K. M. L. Taylor H. An W. Lin W. Lin Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents J. Am. Chem. Soc. 2006 128 9024 9025
27. J. L. Kovar M. A. Simpson A. Schutz - Geschwender D. M. Olive A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models Anal. Biochem. 2007 367 1 12
28. M. F. Kircher U. Mahmood R. S. King R. Weissleder L. Josephson A multimodal nanoparticles for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation Cancer Res. 2003 63 8122 8125
29. P. Kocbek N. Obermajer M. Cegnar J. Kos J. Kristl Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody J. Controlled Release 2007 120 18 26
30. H. S. Thomsen Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide Eur. Radiol. 2006 16 2619 2621
31. H. Cao S.-Y. Xu EDC/NHS-crosslinked type II collagen-chondroitin sulfate scaffold: characterization and in vitro evaluation J. Mater. Sci.: Mater. Med. 2008 19 567 575
32. B. Steitz H. Hofmann S. W. Kamau P. O. Hassa M. O. Hottiger B. von Rechenberg M. Hofmann-Amtenbrink A. Petri-Fink Characterization of PEI-coated superparamagnetic iron oxide nanoparticles for transfection: size distribution, colloidal properties and DNA interaction J. Magn. Magn. Mater. 2007 311 300 305
33. H. Duan M. Kuang X. Wang Y. A. Wang H. Mao S. Nie Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: new insights into spin disorder and proton relaxivity J. Phys. Chem. C 2008 112 8127 8131
34. F. Yu Y. Huang A. J. Cole V. C. Yang The artificial peroxidase activity of magnetic iron oxide nanoparticles and its application to glucose detection Biomaterials 2009 30 4716 4722
35. X. Xu J.-F. Zhang Y. Fan Fabrication of cross-linked polyethyleneimine microfibers by reactive electrospinning with in situ photo-cross-linking by UV radiation Biomacromolecules 2010 11 2283 2289
36. I. Yudovin-Farber N. Beyth E. I. Weiss A. J. Domb Antibacterial effect of composite resins containing quaternary ammonium polyethyleneimine nanoparticles J. Nanopart. Res. 2010 12 591 603
37. C. Liu P. Zhang X. Zhai F. Tian W. Li J. Yang Y. Liu H. Wang W. Wang W. Liu Nano-carrier for gene delivery and bioimaging based on carbon dots with PEI-passivation enhanced fluorescence Biomaterials 2012 33 3604 3613
38. M. K. Corbierre N. S. Cameron R. B. Lennox Polymer-stabilized gold nanoparticles with high grafting densities Langmuir 2004 20 2867 2873
39. R. C. Weast, CRC Handbook of Chemistry and Physics, 65th edn, Boca Raton, CRC Press, Inc., 1984-1985. p. B-96
40. 3 Phys. Rev. B 1975 11 1609 1622
41. 1 MR images, and account for relaxivities ACS Appl. Mater. Interfaces 2010 2 10 2949 2955
42. P. Reimer T. Balzer Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications Eur. Radiol. 2003 13 1266 1276
43. C. W. Jung P. Jacobs Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil Magn. Reson. Imaging 1995 13 5 661 674
44. F. A. Cotton and G. Wilkinson, Advanced Inorganic Chemistry, 4th edn, A Wiley-Interscience Publication, New York, 1980, p. 984
45. J. Lodhia G. Mandarano N. J. Ferris P. Eu S. F. Cowell Development and use of iron oxide nanoparticles (Part 1): synthesis of iron oxide nanoparticles for MRI Biomed. Imaging Interv. J. 2010 6 2 e12
46. A. C. Hunter Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity Adv. Drug Delivery Rev. 2006 58 1523 1531
47. M. Breunig U. Lungwitz R. Liebl A. Goepferich Breaking up the correlation between efficacy and toxicity for nonviral gene delivery Proc. Natl. Acad. Sci. U. S. A. 2007 104 14454 14459
48. B. E. V. Beers C. Sempoux R. Materne M. Delos A. M. Smith Biodistribution of ultrasmall iron oxide particles in the rat liver J. Magn. Reson. Imaging 2001 13 594 599
49. R. Weissleder G. Elizondo J. Wittenberg C. A. Rabito H. H. Bengele L. Josephson Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging Radiology 1990 175 489 493